ZANNETTI, BEATRICE ANNA
 Distribuzione geografica
Continente #
NA - Nord America 1.804
AS - Asia 1.559
EU - Europa 1.147
AF - Africa 118
SA - Sud America 79
OC - Oceania 4
Totale 4.711
Nazione #
US - Stati Uniti d'America 1.776
CN - Cina 442
SG - Singapore 413
VN - Vietnam 396
GB - Regno Unito 244
IT - Italia 205
SE - Svezia 158
DE - Germania 146
HK - Hong Kong 78
FR - Francia 77
IN - India 68
BR - Brasile 57
RU - Federazione Russa 55
NL - Olanda 53
CI - Costa d'Avorio 45
IE - Irlanda 42
KR - Corea 41
FI - Finlandia 40
UA - Ucraina 35
ZA - Sudafrica 30
JP - Giappone 29
TG - Togo 23
BE - Belgio 19
CA - Canada 18
EE - Estonia 18
BG - Bulgaria 17
PH - Filippine 15
BD - Bangladesh 11
TH - Thailandia 11
AR - Argentina 10
JO - Giordania 10
SC - Seychelles 9
ES - Italia 8
ID - Indonesia 8
MX - Messico 8
CH - Svizzera 6
NG - Nigeria 6
PL - Polonia 6
TW - Taiwan 6
IQ - Iraq 5
AU - Australia 4
EC - Ecuador 4
IR - Iran 4
TR - Turchia 4
AT - Austria 3
LB - Libano 3
PT - Portogallo 3
PY - Paraguay 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
LT - Lituania 2
RO - Romania 2
CL - Cile 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
KZ - Kazakistan 1
LV - Lettonia 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
PS - Palestinian Territory 1
SI - Slovenia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.711
Città #
Singapore 288
Ashburn 231
Southend 207
Chandler 176
Fairfield 170
Hefei 96
Ann Arbor 94
Woodbridge 92
Ho Chi Minh City 89
Wilmington 82
Seattle 78
Hong Kong 74
Houston 66
San Jose 66
Hanoi 58
Beijing 56
Cambridge 53
Princeton 46
Abidjan 45
Bologna 43
Dublin 42
Seoul 40
Helsinki 36
Santa Clara 35
Boardman 34
Dong Ket 34
Los Angeles 34
New York 34
Lauterbourg 23
Lomé 23
Westminster 21
Tokyo 20
Jinan 19
Padova 19
Brussels 18
Bremen 17
Council Bluffs 17
Nanjing 16
Sofia 16
Berlin 14
Da Nang 14
Frankfurt am Main 14
Jacksonville 14
Florence 13
Milan 13
Turin 13
Changsha 12
Guangzhou 12
Redondo Beach 12
Redwood City 11
Saint Petersburg 11
Amman 10
Haiphong 10
Munich 10
São Paulo 10
Paris 9
San Diego 9
Shenyang 9
Toronto 9
Zhengzhou 9
Bengaluru 8
Chicago 8
Genoa 8
Hyderabad 8
Nanchang 8
Rome 8
Jiaxing 7
Abeokuta 6
Buffalo 6
Can Tho 6
Dallas 6
Dearborn 6
Jakarta 6
London 6
Orem 6
Phoenix 6
Shanghai 6
Dresden 5
Falls Church 5
Hebei 5
Tianjin 5
Washington 5
Bangkok 4
Bern 4
Bexley 4
Bắc Giang 4
Chengdu 4
Forlì 4
Hangzhou 4
Hải Dương 4
Medford 4
Monmouth Junction 4
Mülheim 4
Nuremberg 4
Ottawa 4
Piscataway 4
Salt Lake City 4
San Francisco 4
Baghdad 3
Cape Town 3
Totale 3.056
Nome #
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 338
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment 265
Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma. 249
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma. 246
Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes 232
Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma 204
Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma 203
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens 197
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma 197
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis 194
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents 175
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma 175
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 174
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 174
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment 172
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 172
Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma. 171
Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease. 155
Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5 153
Novel insights and therapeutic approaches in secondary AML 144
Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy 143
SIRT Regulates the Molecular Interaction Between c-MYC and HIF-1α in Multiple Myeloma 141
Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis. 134
New Horizons in Immunology and Immunotherapy of Acute Leukemias and Related Disorders 123
Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct Genotype 120
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 90
Overview on novel strategies and current guidelines for hematopoietic stem cell mobilisation and collection 62
Totale 4.803
Categoria #
all - tutte 12.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.354


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021133 0 0 0 0 0 0 0 0 0 17 17 99
2021/2022520 67 25 26 47 47 19 6 34 13 53 86 97
2022/2023611 54 97 26 97 41 57 11 37 108 15 47 21
2023/2024199 15 23 12 25 16 63 13 9 1 8 6 8
2024/2025651 32 91 54 43 79 28 55 20 7 82 42 118
2025/20261.561 173 150 127 151 180 90 146 44 392 108 0 0
Totale 4.803